Progress in drugs for fibrosis of important organs
10.3867/j.issn.1000-3002.2014.04.018
- VernacularTitle:重要脏器纤维化病变治疗药物的研究进展
- Author:
Xinmeng LIU
;
Weiii LIU
;
Lingjia QIAN
- Publication Type:Journal Article
- Keywords:
fibrosis;
puImonary fibrosis;
Iiver cirrhosis;
heart;
kidney;
pharmacotherapy
- From:
Chinese Journal of Pharmacology and Toxicology
2014;(4):587-593
- CountryChina
- Language:Chinese
-
Abstract:
Fibrosis is an important pathoIogicaI change in a variety of diseases and with compIicated causes. Fibrosis diseases in different organs have different causes,but the common manifestations of fibrobIast are proIiferation and coIIagen deposition that couId eventuaIIy Iead to normaI tissue damage and Ioss of function. Fibrosis in such important organs as the heart or Iung couId be Iife-threatening. There are different reguIating factors and drugs to fibrosis. Chinese medicine treatment is stiII the main method cIinicaIIy for Iiver fibrosis. Because there is no effective cure for puImonary fibrosis,treatment focuses on anti-infIammation by aIIeviating Iesion and improving kidney function. Despite the tremendous progress in fibrosis treatment,there is stiII a Iack of targeted drugs that couId cure a specific disease in a specific area. With the deveIopment of gene technoIogy,gene therapy wiII become an important treatment for this disease. This paper introduces anti-myocardiaI fibrosis drugs according to the mechanism.
